Certified by Founder Lodge
KROMATID®
United States - Longmont, Colorado
START UP
1 Disclosed Funding Rounds $8,000,000
0 Participating Investments
-
Founded date
2007
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Revolutionizing gene editing analysis for precision medicine and cutting-edge research.
For cell and gene therapy researchers, biotech and pharma companies, and regulatory professionals,
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| August, 21 ,2025 | Series C | $8,000,000 |
BroadOak Capital Partners
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Opti | $20,000,000 | (Nov 25, 2025)
Interface | $3,500,000 | (Nov 25, 2025)
Cordance Medical | $8,000,000 | (Nov 25, 2025)
AI One | $7,000,000 | (Nov 25, 2025)
Votre | $3,750,000 | (Nov 25, 2025)